SUJATA TIDD: Open Payments
NPI 1265158679 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$259 in 9 payments from 7 companies in 2025. Trend: 2023 $508 · 2024 $625 · 2025 $259
Food & beverage: $159Education: $100
| Company | Payments | Amount |
|---|---|---|
| HARMONY BIOSCIENCES LLC | 1 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Axsome Therapeutics, Inc. | 1 | $32 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| GENZYME CORPORATION | 1 | $26 |
| Lilly USA, LLC | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: GLASSIA, Sunosi, TRELEGY ELLIPTA, DUPIXENT, ZEPBOUND.
Industry payments across IN — which companies pay providers there.
